New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
12:28 EDTARB, NLSN, SWHC, RGR, GALE, GTATOn The Fly: Midday Wrap
Stocks on Wall Street were markedly higher at midday as optimism surrounding the fiscal cliff negotiations continues to spur buying. Investors have been paying less attention to recent economic reports to focus instead on the fiscal cliff, as demonstrated by the NAHB Housing Market index prompting little reaction, despite its highest reading since April 2006. The averages moved to session highs following comments from both sides of Washington's negotiating table that they hope a deal can still be reached... ECONOMIC EVENTS: In the U.S., the National Association of Home Builders index of builder confidence increased to 47, as was forecast. Also, the current-account deficit in the U.S. narrowed in the third quarter to $107.5B from a $118.1B shortfall in the prior quarter. Economists expected the deficit would narrow to about $103B... COMPANY NEWS: Gunmakers Smith & Wesson (SWHC) and Sturm, Ruger (RGR) continued their recent weakness as a Wall Street Journal cover story highlighted some of the ways American companies are distancing themselves from guns and their makers amid a public outcry in the aftermath of last week's tragedy in Connecticut. Among the recent developments underscored was the decision from private equity firm Cerberus Capital Management to put gunmaker Freedom Group up for sale... MAJOR MOVERS: Among the notable gainers was Arbitron (ARB), up over 23% after agreeing to be bought by Nielsen (NLSN) for $48 per share in cash. Shares of acquirer Nielsen also rose about 3%. Among the noteworthy losers was Galena Biopharma (GALE), down 17% after it sold common stock and warrants to purchase additional shares in a public offering. Also lower was GT Advanced Technologies (GTAT), which was downgraded at Raymond James and Stifel Nicolaus and saw its shares slide more than 12% after issuing guidance well below Street expectations... INDICES: Near noon, the Dow was up 83.20, or 0.63%, to 13,318.59; the Nasdaq was up 33.89, or 1.13%, to 3,044.49; and the S&P 500 was up 11.60, or 0.81%, to 1,441.96.
News For ARB;NLSN;SWHC;RGR;GALE;GTAT From The Last 14 Days
Check below for free stories on ARB;NLSN;SWHC;RGR;GALE;GTAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
15:46 EDTGALEGalena in-license of Zuplenz makes sense, says Piper Jaffray
Subscribe for More Information
09:55 EDTGALEGalena 'stands little chance' of improving Zuplenz sales, TheStreet says
After Galena BioPharma entered into a license agreement with MonoSol Rx for Zuplenz, TheStreet's Adam Feuerstein predicted that the company "stands little chance of delivering higher sales of Zuplenz than its previous marketer," calling the drug one that "no one wants" and "something to promote while waiting for the phase III study of NeuVax in breast cancer to inevitably fail." Reference Link
09:03 EDTNLSNNielsen, Pointlogic announce alliance
Subscribe for More Information
07:21 EDTGALEGalena enters into licensing agreement with MonoSol Rx
MonoSol Rx announced that it has licensed Zuplenz to Galena Biopharma. Zuplenz is an oral soluble film, or OSF, for the prevention of chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting. The licensing agreement includes an undisclosed upfront payment from Galena, as well as double digit royalty payments from sales of Zuplenz. Zuplenz is the first oral soluble lingual film product approved by the FDA as a prescription medication, based on MonoSol Rx's proprietary PharmFilm technology.
July 17, 2014
12:44 EDTNLSNNielsen downgraded to Hold from Buy at Pivotal Research
Subscribe for More Information
July 16, 2014
07:24 EDTNLSNSiemer & Associates to hold a summit
Subscribe for More Information
July 15, 2014
06:13 EDTNLSNFacebook, Nielsen team up to track TV habits, LA Times reports
Subscribe for More Information
July 14, 2014
10:18 EDTGTATGT Advanced retreats after downgrade citing production concerns
Subscribe for More Information
07:41 EDTGTAT, GTATGT Advanced 's 2014 guidance at risk, says CLSA
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use